PatientsVille.com Logo

Bendrofluazide Side Effects

PatientsVille

Common Bendrofluazide Side Effects


The most commonly reported Bendrofluazide side effects (click to view or check a box to report):

Fall (4)
Hypotension (4)
Chest Pain (4)
Dehydration (3)
Diarrhoea (3)
Cerebrovascular Accident (3)
Haematemesis (3)
Dizziness (3)
Ear Congestion (3)
Nausea (3)
Staphylococcal Infection (2)
Sneezing (2)
Pyoderma Gangrenosum (2)
Sympathectomy (2)
Renal Tubular Acidosis (2)
Head Injury (2)
Hyponatraemia (2)
Epistaxis (2)
Gastrointestinal Haemorrhage (2)
Syncope (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Bendrofluazide Side Effects Reported to FDA



Bendrofluazide Side Effect Report#8466176-4
Product Substitution Issue, Impaired Driving Ability, Convulsion
This is a report of a 52-year-old male patient (weight: NA) from United Kingdom, suffering from the following health symptoms/conditions: NA, who was treated with Bendrofluazide (dosage: NA, start time: NS), combined with:
  • Levetiracetam (1000 Mg (500 Mg, 2 In 1 D), Oral)
  • Candesartan
  • Oxcarbazepine
  • Amlodipine
and developed a serious reaction and side effect(s): Product Substitution Issue, Impaired Driving Ability, Convulsion after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Bendrofluazide treatment in male patients, resulting in Product Substitution Issue side effect.
Bendrofluazide Side Effect Report#8440398-0
Convulsion, Product Substitution Issue
This report suggests a potential Bendrofluazide Convulsion side effect(s) that can have serious consequences. A 52-year-old male patient (weight: NA) from United Kingdom was diagnosed with the following symptoms/conditions: NA and used Bendrofluazide (dosage: NA) starting NS. After starting Bendrofluazide the patient began experiencing various side effects, including: Convulsion, Product Substitution IssueAdditional drugs used concurrently:
  • Amlodipine Besylate
  • Oxcarbazepine (750 Mg, Bid)
  • Candesartan Cilexetil
  • Levetiracetam (500 Mg, Bid)
Although Bendrofluazide demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Convulsion, may still occur.
Bendrofluazide Side Effect Report#8430923-8
Pain In Extremity, Dysuria
This Pain In Extremity problem was reported by a health professional from United Kingdom. A 87-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Jan 01, 2006 this consumer started treatment with Bendrofluazide (dosage: NA). The following drugs were being taken at the same time:
  • Simvastatin
  • Indapamide
  • Aspirin
When using Bendrofluazide, the patient experienced the following unwanted symptoms/side effects: Pain In Extremity, DysuriaAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Pain In Extremity, may become evident only after a product is in use by the general population.
Bendrofluazide Side Effect Report#8387418-X
Rectal Haemorrhage, Weight Decreased, Gastrointestinal Carcinoma
This Rectal Haemorrhage side effect was reported by a health professional from United Kingdom. A 70-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Bendrofluazide (drug dosage: Unk), which was initiated on
Dec 21, 2000. Concurrently used drugs:
  • Prazosin (Unk)
  • Sotalol (Unk)
  • Salbutamol (Unk)
  • Enalapril (Unk)
  • Simvastatin (Unk)
  • Somatropin Rdna (0.3 Mg, 1x/day)
  • Hydrocortisone (Unk)
.After starting to take Bendrofluazide the consumer reported adverse symptoms, such as: Rectal Haemorrhage, Weight Decreased, Gastrointestinal CarcinomaThese side effects may potentially be related to Bendrofluazide. The patient was hospitalized.
Bendrofluazide Side Effect Report#8368252-3
Vision Blurred
This is a report of a 74-year-old female patient (weight: NA) from United Kingdom, suffering from the following health symptoms/conditions: hypertension, who was treated with Bendrofluazide Tablets (dosage: NA, start time:
Jan 01, 1998), combined with:
  • Calcichew D3
  • Candesartan
  • Fosamax
  • Aspirin
  • Levothyroxine Sodium
and developed a serious reaction and side effect(s): Vision Blurred after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Bendrofluazide Tablets treatment in female patients, resulting in Vision Blurred side effect.
Bendrofluazide Side Effect Report#8346716-6
Pancreatitis Relapsing
This report suggests a potential Bendrofluazide Pancreatitis Relapsing side effect(s) that can have serious consequences. A 61-year-old male patient (weight: NA) from United Kingdom was diagnosed with the following symptoms/conditions: NA and used Bendrofluazide (dosage: 2.5 Unk, 1x/day) starting
Jan 01, 2009. After starting Bendrofluazide the patient began experiencing various side effects, including: Pancreatitis RelapsingAdditional drugs used concurrently:
  • Amitriptyline Hcl (100 (unk))
  • Insulin
  • Clopidogrel (75 Unk, 1x/day)
  • Tramadol Hydrochloride (Unk)
  • Enbrel (50 Mg, Weekly)
Although Bendrofluazide demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Pancreatitis Relapsing, may still occur.
Bendrofluazide Side Effect Report#8296488-9
Chest Pain, Pneumonia, Hospitalisation, Lung Neoplasm Malignant
This Chest Pain problem was reported by a physician from United Kingdom. A female patient (weight: NA) was diagnosed with the following symptoms/conditions: hypertension,gastrointestinal disorder,rheumatoid arthritis. On NS this consumer started treatment with Bendrofluazide (dosage: NA). The following drugs were being taken at the same time:
  • Omeprazole
  • Methotrexate
  • Humira
  • Meloxicam
  • Methotrexate
  • Lisinopril
  • Omeprazole
When using Bendrofluazide, the patient experienced the following unwanted symptoms/side effects: Chest Pain, Pneumonia, Hospitalisation, Lung Neoplasm MalignantThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Chest Pain, may become evident only after a product is in use by the general population.
Bendrofluazide Side Effect Report#8288567-7
Myocardial Infarction
This Myocardial Infarction side effect was reported by a physician from New Zealand. A male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Bendrofluazide (drug dosage: Unk), which was initiated on NS. Concurrently used drugs:
  • Metformin (Unk)
  • Amlodipine (Unk)
  • Simvastatin (Unk)
  • Varenicline Tartrate (0.5 Mg, 1x/day)
  • Aspirin (Unk)
  • Inhibace (Unk)
.After starting to take Bendrofluazide the consumer reported adverse symptoms, such as: Myocardial InfarctionThese side effects may potentially be related to Bendrofluazide.
Bendrofluazide Side Effect Report#8274241-X
Diabetes Mellitus Inadequate Control, Hypothyroidism
This is a report of a male patient (weight: NA) from United Kingdom, suffering from the following health symptoms/conditions: NA, who was treated with Bendrofluazide (dosage: NA, start time:
Oct 14, 2011), combined with:
  • Lansoprazole
  • Symbicort
  • Singulair
  • Moxonidine
  • Aliskiren
  • Diltiazem Hcl
  • Candesartan Cilexetil
  • Symbicort (200/6 Mcg Two Puffs Twice A Day)
and developed a serious reaction and side effect(s): Diabetes Mellitus Inadequate Control, Hypothyroidism after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Bendrofluazide treatment in male patients, resulting in Diabetes Mellitus Inadequate Control side effect.
Bendrofluazide Side Effect Report#8272539-2
Pulmonary Fibrosis, Pneumocystis Jiroveci Infection, Interstitial Lung Disease
This report suggests a potential Bendrofluazide Pulmonary Fibrosis side effect(s) that can have serious consequences. A 84-year-old male patient (weight: NA) from New Zealand was diagnosed with the following symptoms/conditions: NA and used Bendrofluazide (dosage: NA) starting NS. After starting Bendrofluazide the patient began experiencing various side effects, including: Pulmonary Fibrosis, Pneumocystis Jiroveci Infection, Interstitial Lung DiseaseAdditional drugs used concurrently:
  • Azathioprine
  • Vincristine (Approximately 1 Week After The First Dose Of Rituximab)
  • Rituximab
  • Levothyroxine Sodium
  • Prednisone Tab (Foe 2 Days)
  • Prednisone Tab (Resumed For The Next 3 Months)
  • Warfarin Sodium
  • Prednisone Tab (Dose Was Tapered)
Although Bendrofluazide demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Pulmonary Fibrosis, may still occur.
Bendrofluazide Side Effect Report#8206940-X
Ear Congestion
This Ear Congestion problem was reported by a health professional from United Kingdom. A 56-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: hypertension. On
Sep 09, 2008 this consumer started treatment with Bendrofluazide (dosage: Unk). The following drugs were being taken at the same time:
  • Simvastatin
  • Simvastatin (Unk)
When using Bendrofluazide, the patient experienced the following unwanted symptoms/side effects: Ear CongestionAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Ear Congestion, may become evident only after a product is in use by the general population.
Bendrofluazide Side Effect Report#8201398-9
Ear Congestion
This Ear Congestion side effect was reported by a health professional from United States. A 56-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Bendrofluazide (bendroflumethiazide) (drug dosage: NA), which was initiated on NS. Concurrently used drugs:
  • Simvastatin ((40 Mg), Oral)
  • Simvastatin ((40 Mg), Oral)
.After starting to take Bendrofluazide (bendroflumethiazide) the consumer reported adverse symptoms, such as: Ear CongestionThese side effects may potentially be related to Bendrofluazide (bendroflumethiazide).
Bendrofluazide Side Effect Report#8200152-1
Ear Congestion
This is a report of a 56-year-old female patient (weight: NA) from United Kingdom, suffering from the following health symptoms/conditions: hypertension, who was treated with Bendrofluazide (dosage: NA, start time:
Sep 09, 2008), combined with:
  • Simvastatin
and developed a serious reaction and side effect(s): Ear Congestion after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Bendrofluazide treatment in female patients, resulting in Ear Congestion side effect.
Bendrofluazide Side Effect Report#8176804-9
Linear Iga Disease, Globulins Increased, Alanine Aminotransferase Increased
This report suggests a potential Bendrofluazide (bendroflumethiazide) Linear Iga Disease side effect(s) that can have serious consequences. A 58-year-old female patient (weight: NA) from was diagnosed with the following symptoms/conditions: NA and used Bendrofluazide (bendroflumethiazide) (dosage: NA) starting NS. After starting Bendrofluazide (bendroflumethiazide) the patient began experiencing various side effects, including: Linear Iga Disease, Globulins Increased, Alanine Aminotransferase IncreasedAdditional drugs used concurrently:
  • Amlodipine
Although Bendrofluazide (bendroflumethiazide) demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Linear Iga Disease, may still occur.
Bendrofluazide Side Effect Report#8139184-0
Linear Iga Disease
This Linear Iga Disease problem was reported by a health professional from United Kingdom. A 58-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Bendrofluazide (dosage: 2.5 Mg). The following drugs were being taken at the same time:
  • Amlodipine Besylate
When using Bendrofluazide, the patient experienced the following unwanted symptoms/side effects: Linear Iga DiseaseAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Linear Iga Disease, may become evident only after a product is in use by the general population.
Bendrofluazide Side Effect Report#8137422-1
Hypokalaemia, Hyponatraemia, Hyperammonaemia, Lethargy, Muscular Weakness, Coordination Abnormal, Hyperreflexia, Urinary Tract Infection Enterococcal, Vulvovaginal Discomfort
This Hypokalaemia side effect was reported by a consumer or non-health professional from United Kingdom. A 52-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Bendrofluazide (drug dosage: NA), which was initiated on NS. Concurrently used drugs:
  • Lamotrigine
  • Carbamazepine (600 Mg)
  • Citalopram Hydrobromide
.After starting to take Bendrofluazide the consumer reported adverse symptoms, such as: Hypokalaemia, Hyponatraemia, Hyperammonaemia, Lethargy, Muscular Weakness, Coordination Abnormal, Hyperreflexia, Urinary Tract Infection Enterococcal, Vulvovaginal DiscomfortThese side effects may potentially be related to Bendrofluazide. The patient was hospitalized.
Bendrofluazide Side Effect Report#8047414-9
Herpes Zoster
This is a report of a 75-year-old male patient (weight: NA) from United Kingdom, suffering from the following health symptoms/conditions: NA, who was treated with Bendrofluazide (dosage: NA, start time:
Jan 27, 2010), combined with:
  • Remicade
  • Lansoprazole
  • Aspirin
  • Mycophenolate Mofetil
  • Hydroxyzine
  • Acetaminophen
and developed a serious reaction and side effect(s): Herpes Zoster after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Bendrofluazide treatment in male patients, resulting in Herpes Zoster side effect. The patient was hospitalized.
Bendrofluazide Side Effect Report#8031320-X
Neutropenia, Diarrhoea
This report suggests a potential Bendrofluazide Neutropenia side effect(s) that can have serious consequences. A male patient (weight: NA) from New Zealand was diagnosed with the following symptoms/conditions: NA and used Bendrofluazide (dosage: 2.5mg Per Day) starting
Jan 01, 2007. After starting Bendrofluazide the patient began experiencing various side effects, including: Neutropenia, DiarrhoeaAdditional drugs used concurrently:
  • Thalidomide (100mg Per Day)
  • Metoprolol Tartrate (95mg Per Day)
  • Prednisone Tab
The patient was hospitalized. Although Bendrofluazide demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Neutropenia, may still occur.
Bendrofluazide Side Effect Report#8007119-7
Pyoderma Gangrenosum, Staphylococcal Infection, Limb Injury, Skin Ulcer
This Pyoderma Gangrenosum problem was reported by a physician from United Kingdom. A 81-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: hypertension,metastatic renal cell carcinoma. On
Feb 01, 2011 this consumer started treatment with Bendrofluazide (dosage: 2.5 Mg, Unk). The following drugs were being taken at the same time:
  • Sutent (37.5 Mg, 1x/day)
When using Bendrofluazide, the patient experienced the following unwanted symptoms/side effects: Pyoderma Gangrenosum, Staphylococcal Infection, Limb Injury, Skin UlcerAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Pyoderma Gangrenosum, may become evident only after a product is in use by the general population.
Bendrofluazide Side Effect Report#7994914-3
Pyoderma Gangrenosum, Staphylococcal Infection
This Pyoderma Gangrenosum side effect was reported by a health professional from United Kingdom. A 81-year-old female patient (weight:NA) experienced the following symptoms/conditions: hypertension,metastatic renal cell carcinoma.The patient was prescribed Bendrofluazide (drug dosage: 2.5 Mg, Unk), which was initiated on
Feb 01, 2011. Concurrently used drugs:
  • Sutent (37.5 Mg, 1x/day)
.After starting to take Bendrofluazide the consumer reported adverse symptoms, such as: Pyoderma Gangrenosum, Staphylococcal InfectionThese side effects may potentially be related to Bendrofluazide.
Bendrofluazide Side Effect Report#7984013-9
Blood Potassium Decreased, Hyponatraemia, Confusional State, Blood Cortisol Increased, Blood Creatinine Increased, Blood Osmolarity Decreased, Blood Urea Decreased
This is a report of a 91-year-old female patient (weight: NA) from United Kingdom, suffering from the following health symptoms/conditions: cardiac failure congestive,urinary tract infection, who was treated with Bendrofluazide (dosage: 2.5 Mg, 1x/day, start time:
Dec 29, 2010), combined with:
  • Trimethoprim (200 Mg, 2x/day)
  • Carvedilol (3.75 Mg, Unk)
  • Warfarin Sodium (Unk)
  • Ramipril (10 Mg, 1x/day)
and developed a serious reaction and side effect(s): Blood Potassium Decreased, Hyponatraemia, Confusional State, Blood Cortisol Increased, Blood Creatinine Increased, Blood Osmolarity Decreased, Blood Urea Decreased after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Bendrofluazide treatment in female patients, resulting in Blood Potassium Decreased side effect. The patient was hospitalized.
Bendrofluazide Side Effect Report#7967091-2
Gastrointestinal Haemorrhage, Duodenal Ulcer, Gastric Ulcer, Haematemesis
This report suggests a potential Bendrofluazide Gastrointestinal Haemorrhage side effect(s) that can have serious consequences. A 65-year-old female patient (weight: NA) from United Kingdom was diagnosed with the following symptoms/conditions: hypertension,sciatica and used Bendrofluazide (dosage: 5 Mg, 1x/day) starting
Feb 25, 2011. After starting Bendrofluazide the patient began experiencing various side effects, including: Gastrointestinal Haemorrhage, Duodenal Ulcer, Gastric Ulcer, HaematemesisAdditional drugs used concurrently:
  • Ibuprofen (400 Mg, 3x/day)
  • Amlodipine (15 Mg, 1x/day)
  • Acetaminophen And Codeine Phosphate (1 Df, 4x/day)
  • Naproxen (250 Mg, 3x/day)
The patient was hospitalized. Although Bendrofluazide demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Gastrointestinal Haemorrhage, may still occur.
Bendrofluazide Side Effect Report#7916878-0
Amnesia, Alcohol Intolerance, Disorientation
This Amnesia problem was reported by a health professional from United Kingdom. A 51-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Jan 12, 2011 this consumer started treatment with Bendrofluazide (dosage: NA). The following drugs were being taken at the same time:
  • Omeprazole
  • Sertraline Hydrochloride
  • Vesicare (10 Mg, Uid/qd)
When using Bendrofluazide, the patient experienced the following unwanted symptoms/side effects: Amnesia, Alcohol Intolerance, DisorientationAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Amnesia, may become evident only after a product is in use by the general population.
Bendrofluazide Side Effect Report#7900467-8
Angioedema
This Angioedema side effect was reported by a health professional from United Kingdom. A 53-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Bendrofluazide (drug dosage: NA), which was initiated on
Jun 01, 2010. Concurrently used drugs:
  • Cetirizine Hcl
  • Angitil
  • Cetirizine Hcl
  • Doxazosin Mesylate
  • Aliskiren
  • Aliskiren
  • Amlodipine
  • Bisoprolol
.After starting to take Bendrofluazide the consumer reported adverse symptoms, such as: AngioedemaThese side effects may potentially be related to Bendrofluazide. The patient was hospitalized.
Bendrofluazide Side Effect Report#7887906-6
Angioedema
This is a report of a 53-year-old female patient (weight: NA) from United Kingdom, suffering from the following health symptoms/conditions: NA, who was treated with Bendrofluazide (dosage: Unk, start time:
Jun 01, 2010), combined with:
  • Doxazosin Mesylate (Unk)
  • Cetirizine Hcl (10 Mg, Qd)
  • Angitil (Unk)
  • Amlodipine (Unk)
  • Bisoprolol (Unk)
  • Aliskiren (300 Mg, Qd)
and developed a serious reaction and side effect(s): Angioedema after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Bendrofluazide treatment in female patients, resulting in Angioedema side effect. The patient was hospitalized.


1 of 3 


The appearance of Bendrofluazide on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

Ask a Doctor Online
12 Doctors are Online.
A Question is Answered Every 9 Seconds!
Ask a Doctor >

What are common Bendrofluazide Side Effects for Women?

Women Side EffectsReports
Ear Congestion 3
Fall 3
Hypotension 3
Angioedema 2
Bronchospasm 2
Cataract Operation 2
Chest Pain 2
Dehydration 2
Diarrhoea 2
Duodenal Ulcer 2

What are common Bendrofluazide Side Effects for Men?

Men Side EffectsReports
Blood Sodium Decreased 2
Cerebrovascular Accident 2
Convulsion 2
Haematemesis 2
Head Injury 2
Hypoxia 2
Nausea 2
Oligohydramnios 2
Osteopenia 2
Persistent Foetal Circulation 2

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Bendrofluazide reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Ask a Doctor Online
    12 Doctors are Online.
    A Question is Answered Every 9 Seconds!
    Ask a Doctor >

    Discuss Bendrofluazide Side Effects

    Did You Have a Bendrofluazide Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Bendrofluazide for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Bendrofluazide Safety Alerts, Active Ingredients, Usage Information

    More About Bendrofluazide

    Side Effects reported to FDA: 63

    Bendrofluazide safety alerts: No

    Reported deaths: 6

    Reported hospitalizations: 24

    Latest Bendrofluazide clinical trials